日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / National affairs

Vaccine makers may face harsh penalties for legal violations

By WANG XIAODONG | China Daily | Updated: 2018-11-13 07:45
Share
Share - WeChat
[Photo/VCG]

Vaccine producers could be given harsh penalties for a range of violations, with substantial fines possible, under a new draft law from China's top market regulator after a major quality control scandal earlier this year.

Serious violators could have profits confiscated, certificates revoked, production suspended and face fines of up to 10 times the value of the products in question.

Violations under scrutiny include falsifying manufacturing records and failing to recall products sold after quality issues or other potential safety risks were discovered, according to the draft.

Senior executives and other employees at key posts within offending companies will have their salaries recalled during periods of infraction, and may be required to pay an additional fine of between 50 and 100 percent of their pay. They may be banned from engaging in pharmaceutical activities for life, according to the draft.

The draft was released by the State Administration for Market Regulation on its website and is soliciting public opinion and feedback until Nov 25.

Almost all existing laws were drafted by government departments before they were submitted to legislators for consideration.

Producers of substandard drugs could have their illegal gains confiscated and pay fines of up to three times the value of the products involved, according to the existing Drug Management Law, which covers vaccines and is now undergoing revision.

The draft, once made into law, will prioritize the Drug Management Law and other related laws in the management of vaccines, according to the administration.

Vaccine producers could have their illegal gains confiscated and production suspended, and they would face fines of up to 1 million yuan ($143,000) for violations such as refusing to take effective measures to recall problematical products sold on the market, the draft said.

Vaccine producers must purchase insurance in case they are faced with compensation for substandard products, it said.

"Vaccines relate to people's life and health, public health and national security," the administration said in a statement.

The draft was made in response to public concern over improving supervision of vaccines, and is meant to eliminate loopholes exposed by the case involving Changchun Changsheng Bio-tech Co, it said.

The rabies vaccine producer, based in Changchun, Jilin province, was found to have falsified production records during an unannounced inspection in July by China's top drug authority.

An investigation team announced in August the company had committed other serious violations such as using expired raw materials.

Rabies is almost always fatal if untreated. No injuries or deaths caused by the substandard rabies vaccines produced by the company have been publicly reported so far.

Tao Lina, a Shanghai-based public health expert, said the punitive measures stipulated in the draft will help deter vaccine producers and sellers from violating laws. But how to effectively uncover such violations remains a problem.

"A system that financially rewards whistlerblowers should be established to encourage insiders to report law violations," he said.

Wang Yuedan, a professor of immunology at Peking University, said requiring vaccine producers to buy insurance will ensure compensation for those receiving vaccinations if serious side effects occur, and encourage vaccinations among the public.

"Although many regulations stipulated in the draft have in practice been carried out, they will be better implemented once they become law," he said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 波多野吉衣一区二区三区四区 | 日本福利在线观看 | 色阁阁日韩欧美在线 | 欧美视频三区 | 欧美日韩中文在线 | 欧美激情a∨在线视频播放 中文字幕亚洲图片 | 欧美 日本 国产 | 亚洲AV久久综合无码东京 | 久久亚洲精品国产亚洲老地址 | 久久99综合国产精品亚洲首页 | 四虎影业 | 日本一级特黄视频 | 日韩精品一区二区在线 | 婷婷色中文字幕 | 美国黄色一级片 | 国产精品极品美女自在线看免费一区二区 | 亚洲码欧美码一区二区三区 | asian极品呦女爱爱 | 亚洲精品视频久久久 | 免费一级欧美性大片 | 韩国久久久久无码国产精品 | 日本久久久久久 | 欧美国产成人一区二区三区 | 岛国毛片一级一级特级毛片 | 午夜精品一区二区三区免费视频 | 青青草在线视频免费观看 | 欧美成人欧美激情欧美风情 | 免费一区 | 在线播放一区二区三区 | 亚洲国产欧美在线观看 | 欧美日韩北条麻妃一区二区 | 亚洲国产精品久久久久久网站 | 天天摸天天爽天天澡视频 | 国产精品入口麻豆 | 日本高清视频在线三级 | 一97日本道伊人久久综合影院 | 国产你懂得 | 一区二区中文字幕 | 特黄特色的大片观看免费视频 | 99热这里有免费国内精品 | 久久中文字幕一区二区 |